Syngene International Ltd. Financials

NSE BSE

15:58 Jul 30

Syngene International Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

722.05

+10.65 (+1.50%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

722.05

+10.65 (+1.50%)
15:58 Jul 30

Quality

54/100
Medium Financial Strength

Valuation

32/100
Mid Valuation

Technical

49/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	2604.2	3192.9	3488.6	3642.4	3727.2
Operating Expenses +	1808.1	2258.5	2474.2	2600.6	2648.8
Raw Material	770.6	902.2	873.6	925.4	940.3
Increase Decrease in Cost	-21.6	-42	56.6	17.1	-13.7
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	718.1	841.7	888.7	983.9	1015.7
Miscellaneous Expenses	341	556.6	655.3	674.2	706.5
Operating Profit	796.1	934.4	1014.4	1041.8	1078.4
Other Income	52.8	70.9	90.6	71.8	71.4
Depreciation	309.7	366.5	425.9	432.6	436.9
Interest	24.1	45.2	47.2	53.1	53
Profit before tax and exceptio..	515.1	593.6	631.9	627.9	659.9
Exceptional Items	-30.7	0	-11.1	32	0
PBT	484.4	593.6	620.8	659.9	659.9
Provision for Taxation	88.6	129.2	110.8	163.7	152.7
Net Profit	395.8	464.4	510	496.2	507.2
NET Profit after MI	395.8	464.4	510	496.2	507.2
EPS	9.82	11.51	12.69	12.34	12.63
Operating Profit Margin (%)	30.57	29.26	29.08	28.6	28.93
Net Profit Margin (%)	15.2	14.54	14.62	13.62	13.61

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	52.70	52.70	52.70	54.70	54.70
FII	16.50	19.50	20.60	20.70	20.60
MF	20.70	17.90	15.40	13.60	13.60
Others	3.40	3.60	4.20	3.90	3.20

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: